Application 022377
- Type
- NDA
- Sponsor
- MERIDIAN MEDCL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALSUMA | SUMATRIPTAN SUCCINATE | INJECTABLE;SUBCUTANEOUS | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022377-001 | ALSUMA | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N022377-001 | ALSUMA | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2010-06-29 | f41ea6bd6efb… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N022377-001 | 7811254 | 2027-08-26 | U-1083 | Drug product | 2010-10-13 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Direct_Rx | f6c907a3-9624-f893-e053-6294a90a31af | 2025-01-22 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | NuCare Pharmaceuticals,Inc. | 7628caf4-5272-4e42-e053-2a91aa0a2f24 | 2025-01-08 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | NuCare Pharmaceuticals, Inc. | 2a96f37d-03f6-678c-e063-6394a90ae0c6 | 2024-12-31 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Quality Care Products, LLC | 5d1f3de0-684a-4092-be30-aa325ff20d04 | 2024-12-18 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Quality Care Products, LLC | da77dfc4-551c-4e0e-a65e-cb478f193cd9 | 2024-12-18 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Direct_Rx | 284ee7ac-759e-b592-e063-6394a90a78ba | 2024-12-02 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | NuCare Pharmaceuticals,Inc. | b297a466-7d24-9ebd-e053-2a95a90af4d1 | 2024-07-17 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | NuCare Pharmaceuticals,Inc. | 54c6f8f4-5466-3988-e054-00144ff8d46c | 2024-07-10 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | NuCare Pharmaceuticals,Inc. | 933f6575-a4c4-0f65-e053-2a95a90ab967 | 2024-06-19 | SUMATRIPTAN SUCCINATE | |
| Sumatriptan | SUMATRIPTAN SUCCINATE | NuCare Pharmaceuticals,Inc. | 85295be9-852d-4e21-e053-2991aa0a8a78 | 2024-06-14 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Fresenius Kabi USA, LLC | b183c7ba-2cc6-4854-a9a6-71ccd3592586 | 2024-04-12 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| sumatriptan succinate | SUMATRIPTAN SUCCINATE | A-S Medication Solutions | 97016a59-3b49-4134-85aa-8c866f285601 | 2023-11-22 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | NorthStar Rx LLC | 38fd19bf-b7aa-812c-8a74-2414dfec45f4 | 2023-03-01 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Proficient Rx LP | fe09fab6-b9e3-469c-9a38-bcc343dcc899 | 2023-01-01 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Asclemed USA, Inc. | 77f9f135-e840-48f0-81e8-73e08433e768 | 2022-10-11 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Proficient Rx LP | abbd2168-1523-4eb6-a75c-dc4d7d1b1c9b | 2022-06-01 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Proficient Rx LP | 1042b91c-715c-4e90-b9cc-d91a17f9f7cb | 2022-04-01 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| sumatriptan succinate | SUMATRIPTAN SUCCINATE | Proficient Rx LP | 9f4d487a-c5f7-4707-976b-64e738c98d45 | 2022-04-01 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan Succinate | SUMATRIPTAN SUCCINATE | Dr. Reddy's Laboratories Limited | 4e26764d-ce26-e5ac-e6db-0f1f7a1d5c2b | 2021-12-21 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
| Sumatriptan | SUMATRIPTAN SUCCINATE | Xellia Pharmaceuticals USA LLC | f42c6e00-e693-48f3-8e84-c3f139e1adf5 | 2021-11-18 | Warnings, Adverse reactions | SUMATRIPTAN SUCCINATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.